3EO Health licenses Wyss Institute technology from Harvard, aiming to develop at-home molecular testing with PCR-grade sensitivity and antigen test–level cost
04 août 2022 09h00 HE
|
Wyss Institute at Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University, Aug. 04, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard...
Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases
27 juin 2022 09h00 HE
|
Wyss Institute at Harvard University
Wyss Institute for Biologically Inspired Engineering at Havard University, June 27, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today the Wyss Institute for Biologically Inspired Engineering at Harvard...
Northpond Labs funds second research project at Harvard's Wyss Institute
19 mai 2022 11h00 HE
|
Wyss Institute at Harvard University
Boston, May 19, 2022 (GLOBE NEWSWIRE) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and Northpond Ventures announced today that Northpond Labs, the venture...
Harvard Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics to facilitate infectious and immune disease and cancer diagnostics
07 mars 2022 14h28 HE
|
Wyss Institute at Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University, March 07, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard...
Cantex Licenses IP from Harvard to Develop Repurposed Drug ID'd by Wyss Institute to Treat COVID-19
23 févr. 2022 11h00 HE
|
Wyss Institute at Harvard University
Boston, MA and Weston, FL, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company based in Weston, FL, and the Wyss Institute for Biologically...
Harvard University licenses kidney engineering technology to Trestle Biotherapeutics to facilitate new kidney replacement therapies
22 févr. 2022 14h38 HE
|
Wyss Institute at Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University, Feb. 22, 2022 (GLOBE NEWSWIRE) -- (BOSTON/CAMBRIDGE, Mass.) — A newly launched startup is building upon innovations...
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
10 févr. 2022 08h00 HE
|
Wyss Institute at Harvard University
Boston, MA, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of...
Pluto Biosciences launches from Harvard’s Wyss Institute to speed scientific discovery
16 août 2021 11h00 HE
|
Wyss Institute at Harvard University
Boston, MA, USA, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that a new startup, Pluto Biosciences (Pluto Bio),...
Harvard’s Wyss Institute and Brigham and Women’s Hospital launch Diagnostic Accelerator
09 juil. 2021 07h00 HE
|
Wyss Institute at Harvard University
Boston, July 09, 2021 (GLOBE NEWSWIRE) -- (Boston) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston’s Brigham and Women Hospital (Brigham) announce...